Bioxytran, Inc. (BIXT)
OTCMKTS · Delayed Price · Currency is USD
0.0300
0.00 (0.00%)
May 27, 2026, 1:56 PM EST
Bioxytran Market Cap
Bioxytran has a market cap or net worth of $3.43 million as of May 27, 2026. Its market cap has decreased by -71.28% in one year.
Market Cap
3.43M
Enterprise Value
4.22M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since September 24, 2018, Bioxytran's market cap has decreased from 25.52M to 3.43M, a decrease of -86.58%. That is a compound annual growth rate of -23.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 3.43M | -57.98% |
| Dec 31, 2025 | 8.15M | 4.49% |
| Dec 31, 2024 | 7.80M | -64.29% |
| Dec 29, 2023 | 21.85M | -63.00% |
| Dec 30, 2022 | 59.05M | 33.18% |
| Dec 31, 2021 | 44.34M | 89.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orgenesis | 4.41M |
| GPL Holdings | 4.17M |
| AccuStem Sciences | 4.14M |
| Iterum Therapeutics | 3.96M |
| Enzolytics | 3.38M |
| Eastgate Biotech | 3.17M |
| LakeShore Biopharma | 2.88M |
| Vaccinex | 2.81M |